Roche’s vaginal infection test obtains FDA clearance
Roche has secured US Food and Drug Administration (FDA) clearance for its bacterial vaginosis/candida vaginitis (BV/CV) assay in…
Roche Gets FDA 510(k) Clearance for BV/CV Test
The new PCR test uses clinician-collected or clinician-instructed, self-collected vaginal swab specimens to simultaneously detect organisms associated with…
Roche Receives FDA Clearance for cobas BV/CV Assay, Expanding Women’s Health Diagnostics
Medical research ©kaboompics.com The new molecular test broadens Roche’s sexual-health diagnostics portfolio by enabling simultaneous detection of bacterial…
FDA Clears Roche cobas BV/CV PCR Test for Vaginitis Diagnosis
Roche has received Food and Drug Administration (FDA) 510(k) clearance for its cobas BV/CV assay, a molecular diagnostic…
Roche Receives CE Mark for PCR Test Targeting Bacterial Vaginosis and Candida Vaginitis
Roche announced CE Mark approval for its cobas BV/CV (bacterial vaginosis/candida vaginitis) assay, designed to identify specific bacteria…
![[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong 2025 results with 7% sales growth](https://www.europesays.com/ch/wp-content/uploads/2026/02/84b0110bbf60eb8397db0461bc3549c4-380x220.png)
Roche launches new PCR test to help improve diagnostic accuracy for women affected by vaginitis in countries following the CE Mark
F. Hoffmann-La Roche Ltd The new PCR test aids in the diagnosis of infectious causes of vaginitis through…